NC Xperience PMCF Study( rEPIC04B)
NCT05292105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59
Last updated 2024-01-31
Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of NC Xperience to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with NC Xperience .
Conditions
- Coronary Artery Disease (CAD)
- Ischemic Heart Disease
Interventions
- DEVICE
-
NC Xperience
Coronary dilatation balloon catheter (non compliant)
Sponsors & Collaborators
-
Fundación EPIC
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-26
- Primary Completion
- 2023-04-26
- Completion
- 2023-05-05
Countries
- Spain
Study Locations
More Related Trials
-
Essential Pro Study ( rEPIC04E-HK )
NCT06631157 ·Status: RECRUITING
-
BioFreedom Pharmacokinetic Study
NCT03365492 ·Status: COMPLETED ·Phase: NA
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
NCT00415961 ·Status: TERMINATED ·Phase: NA
-
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
NCT01489449 ·Status: COMPLETED ·Phase: PHASE4
-
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
NCT00531011 ·Status: COMPLETED ·Phase: PHASE4
-
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
NCT01148329 ·Status: COMPLETED
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries
NCT01150500 ·Status: COMPLETED ·Phase: NA
-
Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study
NCT04079192 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study
NCT00828087 ·Status: COMPLETED ·Phase: NA
-
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
NCT01242696 ·Status: COMPLETED
-
Drug Eluting Pantera Lux Catheter Registry
NCT01081366 ·Status: COMPLETED
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
NCT00426049 ·Status: UNKNOWN ·Phase: PHASE3
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction
NCT01839890 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™
NCT01084408 ·Status: TERMINATED ·Phase: PHASE3
-
Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial)
NCT04202172 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
NCT05477940 ·Status: UNKNOWN ·Phase: NA
-
Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study
NCT03567733 ·Status: COMPLETED
-
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
NCT03234348 ·Status: COMPLETED ·Phase: PHASE3
-
PEPCAD III Substudy: Stem Cell Mobilization
NCT00473499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
NCT06353594 ·Status: RECRUITING ·Phase: NA